Gilead posts higher profit as HIV sales rise, helped by prevention drugs

吉利德科学(US:GILD) Reuters·2025-10-31 04:05

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including$ 39 million for its new prevention drug Yeztugo, helping to boost its profit above Wall Stree... ...